MultiCell Technologies, Inc. (MCET)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST
MultiCell Technologies Market Cap
MultiCell Technologies has a market cap or net worth of $5 thousand as of January 23, 2026.
Market Cap
5.00K
Enterprise Value
n/a
Revenue
805.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 24, 1995, MultiCell Technologies's market cap has decreased from 1.53M to 5.00K, a decrease of -99.67%. That is a compound annual growth rate of -17.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 5.00K | - |
| Dec 31, 2025 | 5.00K | - |
| Dec 31, 2024 | 5.00K | - |
| Dec 27, 2023 | 5.00K | - |
| Dec 30, 2022 | 5.00K | - |
| Dec 31, 2021 | 5.00K | -99.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovAccess Global | 6.19K |
| Theralink Technologies | 6.15K |
| Hard to Treat Diseases | 5.82K |
| FluoroPharma Medical | 5.52K |
| Better Therapeutics | 5.45K |
| Syros Pharmaceuticals | 5.37K |
| Panbela Therapeutics | 4.86K |
| Kaleido Biosciences | 4.26K |